Instituto Cardiovascular de Rosario

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Christina Davies, Hongchao Pan, Jon Godwin et al. · The Lancet · 2012 · 2K citations · Full text

Breast Oncology, Long-term Effects, Medicine +7

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

Darryl P. Leong, Koon Teo, Sumathy Rangarajan et al. · The Lancet · 2015 · 1.8K citations · Full text

Prognostic Value, Clinical Epidemiology, Rural Health +7

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Deepak L. Bhatt, Michael Szarek, Bertram Pitt et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text